KARMEN GILMORE: Open Payments
NPI 1285373910 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 10 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $554 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 1 | $189 |
| Paratek Pharmaceuticals, Inc. | 2 | $139 |
| Corcept Therapeutics | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ViiV Healthcare Company | 1 | $119 |
| ABBVIE INC. | 1 | $118 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| AstraZeneca Pharmaceuticals LP | 1 | $87 |
| Eisai Inc. | 1 | $84 |
Products named: NEFFY, NUZYRA, Korlym, Auvelity, MAVYRET, RECORLEV, SAPHNELO, Leqembi.
Industry payments across TX — which companies pay providers there.
